Prada's Stellar Rise: Will it Find its Way Back to SA?

Loading player...
Join us as we discuss Prada's impressive performance in the luxury market, even amidst global economic challenges. We'll explore why this iconic brand could be poised for a triumphant return to South Africa.
With Michael Zahariev, co-founder of Luxity, we'll delve into the factors driving Prada's success, the potential impact of a South African comeback, and the broader outlook for the luxury market in the region. Listen to discover how Prada's innovative spirit and strategic moves are shaping the future of luxury fashion.
4 Nov 2024 1PM English South Africa Business News · Investing

Other recent episodes

Family Business to National Player: Anton Gillis on SA’s Hospitality Future

Platinum Hospitality Holdings is set to announce Anton Gillis as its new CEO — marking a major succession moment for one of SA’s leading family‑built hotel groups. Anton shares what the group is seeing on the ground across its national portfolio, where hospitality demand is growing, how operators are navigating…
27 Jul 1PM 15 min

SA Consumers Under Pressure: Retail Signals & MPC Reality

South Africa’s consumer is flashing warning signs — and two retail updates have sharpened the picture. Cashbuild’s weak building materials demand and Mr Price’s shift toward value purchases reveal households under severe pressure. Market analyst The Finance Ghost unpacks how sticky inflation, high interest rates and the MPC’s cautious stance…
27 Jul 12PM 12 min

Why Women’s Financial Empowerment Is an Economic Multiplier

Women’s financial empowerment has the potential to drive economic growth, strengthen households and create lasting generational wealth. Kaya Biz speaks to Alexandra Nortier, Joint Head of Wealth Management at Investec Wealth & Investment International, about why Investec is backing the JSE SheInvests 2026 initiative, the barriers keeping women out of…
23 Jul 1PM 7 min

Affordable Diabetes Care Arrives in SA with Novo Nordisk

Novo Nordisk South Africa GM Sara Norcross explains the launch of the country’s only authorised copy of semaglutide, manufactured using the identical API, process and device as the originator — but at a more affordable price. We unpack what an authorised copy is, why SAHPRA registration matters, how the Acino…
23 Jul 1PM 14 min

SARB holds rates steady in July MPC – What It Means for You

Momentum economist Tshiamo Masike unpacks the SARB’s decision to pause, the upside inflation surprise, and the global factors driving the MPC’s decision. We explore how rising oil prices, geopolitical tensions, and weakening consumer confidence shaped the call — and what households, businesses and markets should expect next. A sharp, data‑driven…
23 Jul 1PM 14 min